Can lowering blood pressure prevent vascular complications in patients with type 2 diabetes?

摘要

The Action in Diabetes and Vascular disease: preterAx and diamicroN MR Controlled Evaluation (ADVANCE) was a multicenter, randomized, double-blind trial. All patients were aged 55 years or older, had been diagnosed with type 2 diabetes after the age of 30 years, and had either a history of major cardiovascular disease (CVD) or an established risk factor for CVD. There were no inclusion or exclusion criteria relating to BR